Lv3
270 积分 2021-11-17 加入
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
1天前
待确认
早期宫颈癌术后中危因素定义及辅助治疗的研究进展
7天前
已完结
European Society for Medical Oncology (ESMO) congress 2025
29天前
已完结
Clinicopathological study of ovarian carcinoid tumours
1个月前
已完结
Demographics, clinicopathological features, and survival outcomes of women with endometrial neuroendocrine tumors
3个月前
已完结
Selinexor in patients with advanced and recurrent endometrial cancer
3个月前
已完结
The nuclear export protein XPO1 — from biology to targeted therapy
3个月前
已完结
Niraparib: A Review in Ovarian Cancer
1年前
已完结
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
1年前
已完结
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
1年前
已完结
皖公网安备34019202002308
